Results 111 to 120 of about 204,688 (384)

Three‐Year Outcomes From BENEFIT‐EXT: A Phase III Study of Belatacept Versus Cyclosporine in Recipients of Extended Criteria Donor Kidneys

open access: yesAmerican Journal of Transplantation, 2012
Recipients of extended‐criteria donor (ECD) kidneys have poorer long‐term outcomes compared to standard‐criteria donor kidney recipients. We report 3‐year outcomes from a randomized, phase III study in recipients of de novo ECD kidneys (n = 543) assigned
J. M. Pestana   +17 more
semanticscholar   +1 more source

Gingival enlargement following levetiracetam treatment: A clinical case analysis

open access: yesEpilepsia Open, EarlyView.
Abstract This report describes a 21‐year‐old female with a history of epilepsy, diagnosed at age 17, who developed gingival enlargement after being treated with levetiracetam. Her dosage was titrated to 750 mg twice daily, achieving satisfactory seizure control.
Awadh M. Alahmari, Ali M. Alkhathaami
wiley   +1 more source

Orthotopic liver transplantation for alcoholic cirrhosis. [PDF]

open access: yes, 1988
Fifteen patients with Laennec's cirrhosis underwent orthotopic liver transplantation between 1963 and the end of 1979. The first eight patients died perioperatively or within two months, but four of the next seven patients had long survival; three are ...
Gordon, RD   +9 more
core   +1 more source

Donor‐Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation

open access: yesAmerican Journal of Transplantation, 2012
Donor‐specific HLA antibodies (DSA) have a negative impact on kidney graft survival. Therefore, we analyzed the occurrence of DSA and antibody‐mediated rejection (AMR) in patients from two prospective randomized trials in our center.
L. Liefeldt   +12 more
semanticscholar   +1 more source

Histopathological Study of Cyclosporine Pulmonary Toxicity in Rats

open access: yesJournal of Toxicology, 2016
Cyclosporine is considered one of the common worldwide immunosuppressive drugs that are used for allograft rejection prevention. However, articles that address adverse effects of cyclosporine use on the vital organs such as lung are still few. This study
Said Said Elshama   +2 more
doaj   +1 more source

Changing perspectives on liver transplantation in 1988. [PDF]

open access: yes, 1988
After liver transplantation for cancer, there is a high incidence of disease recurrence within 18 to 36 months for most tumors, although there are a small number of long-term survivors.
Gordon, RD, Starzl, TE
core  

Diagnosis and management of reactive infectious mucocutaneous eruption

open access: yesJournal of Hospital Medicine, EarlyView.
Abstract Medicine's clinical understanding of reactive infectious mucocutaneous eruption (RIME) has evolved over time. It was previously described as Mycoplasma pneumoniae‐induced rash and mucositis (MIRM), and before that as a variant of Stevens‐Johnson Syndrome/Toxic Epidermal Necrolysis. Here, we summarize the current understanding of best practices
Nicole Damari   +2 more
wiley   +1 more source

Comparison of the cyclosporine variants A and D by NMR spectroscopy

open access: yesУчёные записки Казанского университета: Серия Естественные науки, 2019
A natural variant of cyclosporine A, cyclosporine D, has been studied using high-resolution NMR spectroscopy in a non-polar solution (chloroform). A complete assignment of the 1H and 13C NMR signals has been made.
P.P. Kobchikova   +3 more
doaj   +1 more source

Oral Cyclosporine Treatment in Dogs: A Review of the Literature

open access: yesJournal of Veterinary Internal Medicine, 2013
Cyclosporine is an immunomodulatory drug used to treat an increasing spectrum of diseases in dogs. Cyclosporine is a calcineurin inhibitor, ultimately exerting its inhibitory effects on T‐lymphocytes by decreasing production of cytokines, such as ...
T. Archer   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy